VARIAZIONI DELL'UROCHINASI PLASMATICA NEI PAZIENTI CON NEOPLASIE DELLA PROSTATA

Translated title of the contribution: Changes in plasma urokinase levels in patients with neoplasia of the prostate

R. Rossi Cesolari, B. Casali, R. Immovilli, S. Spatafora, E. Casolari, P. Rivasi, S. Leoni

Research output: Contribution to journalArticlepeer-review

Abstract

Levels of urokinase-type plasminogen activator antigen (uPA) were determined in plasma of patients with benign and malignant prostatic tumours. Plasma levels of uPA evaluated at T1 (before surgical procedure) and at T2 (after surgical removal of tumour) were, respectively, for cancer and for adenoma: 0.66 ± 0.22 ng/ml vs 0.25 ± 0.13 ng/ml (p <0.01) and 0.22 ± 0.09 ng/ml vs 0.23 ± 0.11 ng/ml (the difference was statistically non significant). When levels of uPA in patients with prostatic tumours were compared to plasma uPA in normal blood donors, only cancer patients at T1 had higher levels of uPA. These results suggest that elevated plasma levels of uPA could be a non-specific marker related to the presence of malignant prostate tissue.

Translated title of the contributionChanges in plasma urokinase levels in patients with neoplasia of the prostate
Original languageItalian
Pages (from-to)93-94
Number of pages2
JournalActa Urologica Italica
Volume7
Issue numberSUPPL. 2
Publication statusPublished - 1993

ASJC Scopus subject areas

  • Urology

Fingerprint

Dive into the research topics of 'Changes in plasma urokinase levels in patients with neoplasia of the prostate'. Together they form a unique fingerprint.

Cite this